A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets

High Incidence of Infectious Diseases Persists, While Treatment Options Remain Scarce

Regular Price: USD 3,950

Special Price USD 3,358

15% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 3,358

PAY BY INVOICE

Be the first to review this product

Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well as drugs in clinical trial, is given for each disease type. Key statistics include the relative prevalence of each disease in Latin America. Conclusions and recommendations are also provided. The base year is 2012, with some timelines extending to 2018.

Table of Contents

A Product and Pipeline Analysis of the Latin American Infectious Diseases Therapeutics MarketAnalysis of the Latin American Therapeutics Market for Infectious DiseasesTherapeutics Market for Infectious Diseases in Latin America




Keyword1

Keyword2

Keyword3

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.